Frederick M. Hudson is Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 5 open-market trades across 1 company since 2012, most recently 2026-03-12.
CIK 0001438462
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2012, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 60,413 | $2.3M |
| VCRT | 184,981 | — |
| Total | $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-16 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL | 2026-03-12 | 2026-03-16 | $50.61 | $272K | +1.3% | -0.4% | -12.6% |
| SUPN | SELL | 2025-08-14 | 2025-08-18 | $42.26 | $630K | +5.6% | +4.3% | +5.0% |
| SUPN | SELL | 2024-11-08 | 2024-11-12 | $36.28 | $633K | -4.5% | -4.7% | -0.0% |
| SUPN | SELL | 2023-11-15 | 2023-11-17 | $28.50 | $408K | -0.7% | -0.6% | +4.4% |
| SUPN | SELL · 10b5-1 | 2020-07-13 | 2020-07-15 | $24.44 | $22K | -2.7% | -1.0% | -14.3% |
| SUPN | BUY | 2012-05-04 | 2012-05-07 | $5.00 | $25K | -17.4% | -0.2% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.